Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346838 · ClinicalTrials.gov registry record · NA
Prebiotics, Gut Microbiota, and Cardiometabolic Health
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02346838 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 22 participants.
The verdict
NCT02346838, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Forty-eight prediabetic men and women (50-75 years of age) will participate in a 6-week feeding study in which they will randomized to receive either 10 g/day of inulin or placebo. All subjects will be fed an isocaloric diet (50% carbohydrate, 35% fat, 15% protein,) controlled for micronutrient content for 6 weeks to avoid the potential confound of individual differences in diet on gut microbiota. Measurements of intestinal permeability, insulin sensitivity, and skeletal muscle metabolic flexibility will be made prior to and following the controlled feeding period. Stool samples will be collected to assess gut microbial communities.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Inulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-01 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02346838
The ClinicalTrials.gov registry entry for NCT02346838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02346838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02346838 about?
NCT02346838 is a clinical study titled "Prebiotics, Gut Microbiota, and Cardiometabolic Health". Forty-eight prediabetic men and women (50-75 years of age) will participate in a 6-week feeding study in which they will randomized to receive either 10 g/day of inulin or placebo. All subjects will be fed an isocaloric diet (50% carbohydrate, 35% fat, 15% protein,) controlled for micronutrient cont...
What is the current status of trial NCT02346838?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2014-01. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02346838?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Inulin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02346838?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.